carnitine has been researched along with Colorectal Cancer in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We demonstrate that colorectal cancer cells utilize both a carnitine-dependent and carnitine-independent mechanism that contributes to butyrate oxidation." | 5.43 | Cellular Metabolism and Dose Reveal Carnitine-Dependent and -Independent Mechanisms of Butyrate Oxidation in Colorectal Cancer Cells. ( Bennett, N; Donohoe, DR; Han, A; Johnstone, M; MacDonald, A; Whelan, J, 2016) |
| "Associations between pre-diagnostic levels of 120 circulating metabolites (acylcarnitines, amino acids, biogenic amines, phosphatidylcholines, sphingolipids, and hexoses) and the risks of breast, prostate, and colorectal cancer were evaluated by Cox regression analyses using data of a prospective case-cohort study including 835 incident cancer cases." | 3.83 | Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study. ( Boeing, H; Floegel, A; Johnson, T; Kaaks, R; Kühn, T; Otto, W; Rolle-Kampczyk, U; Sookthai, D; von Bergen, M, 2016) |
| "Early diagnosis of colorectal cancer (CRC) simplifies treatment and improves treatment outcomes." | 1.48 | A quantitative multimodal metabolomic assay for colorectal cancer. ( Bathe, OF; Buie, WD; Farshidfar, F; Hilsden, R; Kopciuk, KA; MacLean, A; Mazurak, VC; McGregor, SE; Vogel, HJ, 2018) |
| "We demonstrate that colorectal cancer cells utilize both a carnitine-dependent and carnitine-independent mechanism that contributes to butyrate oxidation." | 1.43 | Cellular Metabolism and Dose Reveal Carnitine-Dependent and -Independent Mechanisms of Butyrate Oxidation in Colorectal Cancer Cells. ( Bennett, N; Donohoe, DR; Han, A; Johnstone, M; MacDonald, A; Whelan, J, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Brezmes, J | 1 |
| Llambrich, M | 1 |
| Cumeras, R | 1 |
| Gumà, J | 1 |
| van Roekel, EH | 1 |
| Bours, MJL | 1 |
| van Delden, L | 1 |
| Breukink, SO | 1 |
| Aquarius, M | 1 |
| Keulen, ETP | 1 |
| Gicquiau, A | 1 |
| Viallon, V | 1 |
| Rinaldi, S | 1 |
| Vineis, P | 1 |
| Arts, ICW | 1 |
| Gunter, MJ | 1 |
| Leitzmann, MF | 1 |
| Scalbert, A | 1 |
| Weijenberg, MP | 1 |
| Jing, Y | 1 |
| Wu, X | 1 |
| Gao, P | 1 |
| Fang, Z | 1 |
| Wu, J | 1 |
| Wang, Q | 1 |
| Li, C | 1 |
| Zhu, Z | 1 |
| Cao, Y | 1 |
| Farshidfar, F | 1 |
| Kopciuk, KA | 1 |
| Hilsden, R | 1 |
| McGregor, SE | 1 |
| Mazurak, VC | 1 |
| Buie, WD | 1 |
| MacLean, A | 1 |
| Vogel, HJ | 1 |
| Bathe, OF | 1 |
| Han, A | 1 |
| Bennett, N | 1 |
| MacDonald, A | 1 |
| Johnstone, M | 1 |
| Whelan, J | 1 |
| Donohoe, DR | 1 |
| Kühn, T | 1 |
| Floegel, A | 1 |
| Sookthai, D | 1 |
| Johnson, T | 1 |
| Rolle-Kampczyk, U | 1 |
| Otto, W | 1 |
| von Bergen, M | 1 |
| Boeing, H | 1 |
| Kaaks, R | 1 |
1 review available for carnitine and Colorectal Cancer
| Article | Year |
|---|---|
Urine NMR Metabolomics for Precision Oncology in Colorectal Cancer.
Topics: Acetates; Acetone; Biomarkers; Carnitine; Colorectal Neoplasms; Creatinine; Glucose; Humans; Lysine; | 2022 |
5 other studies available for carnitine and Colorectal Cancer
| Article | Year |
|---|---|
Longitudinal associations of physical activity with plasma metabolites among colorectal cancer survivors up to 2 years after treatment.
Topics: Aged; Arginine; Cancer Survivors; Carnitine; Citrulline; Colorectal Neoplasms; Exercise; Female; His | 2021 |
Rapid differentiating colorectal cancer and colorectal polyp using dried blood spot mass spectrometry metabolomic approach.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Carnitine; Colonic Polyps; Colorectal Neoplasms; Dried | 2017 |
A quantitative multimodal metabolomic assay for colorectal cancer.
Topics: Adenoma; Aged; Amino Acids; Biomarkers, Tumor; Carnitine; Colorectal Neoplasms; Early Detection of C | 2018 |
Cellular Metabolism and Dose Reveal Carnitine-Dependent and -Independent Mechanisms of Butyrate Oxidation in Colorectal Cancer Cells.
Topics: Acetylation; Antineoplastic Agents; Butyric Acid; Carnitine; Carnitine O-Palmitoyltransferase; Color | 2016 |
Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study.
Topics: Biomarkers, Tumor; Breast Neoplasms; Carnitine; Cohort Studies; Colorectal Neoplasms; Female; Humans | 2016 |